Cellular Biomedicine Group, Inc. CBMG
No live quote for CBMG yet.
CBMG revenue history
Revenue is income from the company’s ordinary business activities.
339,920 USD
FY 2019 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2019 | 2019-12-31 | 339,920 | 115,517 | 51.48% |
| FY 2018 | 2018-12-31 | 224,403 | -112,414 | -33.38% |
| FY 2017 | 2017-12-31 | 336,817 | -291,113 | -46.36% |
| FY 2016 | 2016-12-31 | 627,930 | -1,877,493 | -74.94% |
| FY 2015 | 2015-12-31 | 2,505,423 | 1,941,046 | 343.93% |
| FY 2014 | 2014-12-31 | 564,377 | 359,463 | 175.42% |
| FY 2013 | 2013-12-31 | 204,914 | -68,706 | -25.11% |
| FY 2012 | 2012-12-31 | 273,620 | 238,120 | 670.76% |
| FY 2011 | 2011-12-31 | 35,500 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:04.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.